COP · Conocophillips - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · COP

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$58.94B	$54.74B	$56.14B	$78.49B	$48.35B	$19.26B
Cost of Revenue	$22.32B	$20.01B	$21.98B	$33.97B	$18.16B	$8.08B
Gross Profit	$36.62B	$34.73B	$34.17B	$44.52B	$30.19B	$11.18B
R&D	$78.00M	$81.00M	$81.00M	$71.00M	$62.00M	$75.00M
SG&A	$893.00M	$1.16B	$705.00M	$623.00M	$719.00M	$430.00M
Total Operating Expenses	$10.33B	$8.75B	$7.69B	$7.01B	$5.69B	$4.34B
D&A	$11.50B	$9.60B	$8.27B	$7.50B	$7.21B	$5.52B
Operating Income	$12.66B	$13.67B	$16.29B	$28.23B	$12.71B	($3.14B)
Interest Expense	$1.18B	$941.00M	$824.00M	$791.00M	$887.00M	$788.00M
Income Tax	$4.67B	$4.43B	$5.33B	$9.55B	$4.63B	($485.00M)
Net Income	$7.99B	$9.24B	$10.96B	$18.68B	$8.08B	($2.70B)
EPS - Basic	$6.36	$7.82	$9.08	$14.62	$6.09	($2.51)
EPS - Diluted	$6.35	$7.81	$9.06	$14.57	($2.51)	-

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$6.50B	$5.61B	$5.63B	$6.46B	$5.03B	$2.99B
Accounts Receivable	-	-	-	-	-	-
Inventory	$1.87B	$1.81B	$1.40B	$1.22B	$1.21B	$1.00B
Accounts Payable	$6.22B	-	-	$6.11B	$5.00B	$2.67B
Current Assets	$15.53B	$15.65B	$14.33B	$18.75B	$16.05B	$12.07B
Total Assets	$121.94B	$122.78B	$95.92B	$93.83B	$90.66B	$62.62B
Current Liabilities	$11.97B	$12.12B	$10.01B	$12.85B	$12.02B	$5.37B
Long-term Debt	-	-	-	-	-	-
Total Liabilities	$57.45B	$57.98B	$46.65B	$45.83B	$45.26B	$32.77B
Stockholders' Equity	$64.49B	$64.80B	$49.28B	$48.00B	$45.41B	$29.85B
Retained Earnings	$68.86B	$64.87B	$59.27B	$53.03B	$40.67B	$35.21B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$19.80B	$20.12B	$19.96B	$28.31B	$17.00B	$4.80B
Investing Cash Flow	($8.84B)	($11.15B)	($12.00B)	($8.74B)	($8.54B)	($4.12B)
Financing Cash Flow	($10.10B)	($8.84B)	($8.66B)	($18.05B)	($6.33B)	($2.71B)
CapEx	-	-	-	$10.16B	$5.32B	$4.71B
Free Cash Flow	-	-	-	$18.16B	$11.67B	$87.00M

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	62.1%	63.4%	60.9%	56.7%	62.4%	58.0%
Operating margin	21.5%	25.0%	29.0%	36.0%	26.3%	-16.3%
EBITDA margin	41.0%	42.5%	43.7%	45.5%	41.2%	12.4%
Net margin	13.6%	16.9%	19.5%	23.8%	16.7%	-14.0%
Free cash flow margin	-	-	-	23.1%	24.1%	0.5%
FCF / Net income	-	-	-	0.97	1.44	-0.03
R&D / Revenue	0.1%	0.1%	0.1%	0.1%	0.1%	0.4%
SG&A / Revenue	1.5%	2.1%	1.3%	0.8%	1.5%	2.2%
Effective tax rate	36.9%	32.4%	32.7%	33.8%	36.4%	-
Return on assets	6.6%	7.5%	11.4%	19.9%	8.9%	-4.3%
Return on equity	12.4%	14.3%	22.2%	38.9%	17.8%	-9.0%
Return on invested capital	-	-	-	-	-	-
Liquidity
Current ratio	1.30	1.29	1.43	1.46	1.34	2.25
Quick ratio	1.14	1.14	1.29	1.36	1.23	2.06
Cash ratio	0.54	0.46	0.56	0.50	0.42	0.56
Leverage
Debt / Equity	-	-	-	-	-	-
Debt / Assets	-	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-
Interest coverage	10.8x	14.5x	19.8x	35.7x	14.3x	-4.0x
Equity multiplier	1.89	1.89	1.95	1.95	2.00	2.10
Liabilities / Assets	0.47	0.47	0.49	0.49	0.50	0.52
Efficiency
Asset turnover	0.48	0.45	0.59	0.84	0.53	0.31
Inventory turnover	11.92	11.06	15.72	27.87	15.03	8.06
Days sales outstanding	-	-	-	-	-	-
Days inventory outstanding	31d	33d	23d	13d	24d	45d
Days payable outstanding	102d	-	-	66d	101d	121d
Cash conversion cycle	-	-	-	-	-	-
Valuation
P / E	14.7x	12.7x	12.8x	8.1x	-	-
P / B	1.8x	1.8x	2.8x	3.1x	0.0x	0.0x
P / S	2.0x	2.1x	2.5x	1.9x	0.0x	0.0x
EV / EBITDA	4.6x	4.8x	5.5x	4.0x	-0.2x	-1.2x
Growth
Revenue growth (YoY)	7.7%	-2.5%	-28.5%	62.3%	151.1%	-47.5%
Revenue CAGR (3y)	-9.1%	4.2%	42.9%	28.9%	7.7%	-16.1%
Revenue CAGR (5y)	25.1%	8.3%	7.7%	19.2%	14.7%	-9.0%
Gross profit growth (YoY)	5.4%	1.7%	-23.3%	47.5%	170.1%	-55.0%
Operating income growth (YoY)	-7.4%	-16.1%	-42.3%	122.1%	-	-
Net income growth (YoY)	-13.6%	-15.6%	-41.3%	131.2%	-	-
EPS growth (YoY)	-18.7%	-13.8%	-37.8%	-	-	-
EPS CAGR (3y)	-24.2%	-	-	-	-	-
EPS CAGR (5y)	-	-	-	-	-	-
FCF growth (YoY)	-	-	-	55.5%	13316.1%	-98.1%
FCF CAGR (5y)	-	-	-	48.8%	-	-
Book value growth (YoY)	-0.5%	31.5%	2.7%	5.7%	52.1%	-14.7%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$121.86B total

Total Segments$60.90B · 50.0%

Lower Forty Eight Segment$41.40B · 34.0%

Europe Middle East And North Africa Segment$6.49B · 5.3%

Alaska Segment$5.64B · 4.6%

Canada Operating Segment$5.60B · 4.6%

Asia Pacific Operating Segment$1.77B · 1.5%

Corporate Segment$63.00M · 0.1%

Geographic

$58.94B total

US$46.61B · 79.1%

Non Us$12.33B · 20.9%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

1.78

Grey zone

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

5/9

Neutral

✓Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
-Long-term debt decreased
✓Current ratio improved
✗No share dilution
✗Gross margin improved
✓Asset turnover improved

Peer comparison

Same SIC group: Petroleum Refining

Company	Revenue (last FY)	Net margin	ROE
CVX	$189.03B	6.5%	6.6%
PBF	$29.33B	-0.5%	-3.0%
MPC	$132.70B	3.0%	23.4%
PSX	$132.38B	3.3%	15.1%
DK	$10.72B	-0.2%	-4.2%

Comparing CONOCOPHILLIPS against the 5 most active filers in the same SIC group.

Dividends

$3.30/share trailing 12 months · +5.8% YoY

Ex-date	Per share
May 11, 2026	$0.8400
Feb 18, 2026	$0.8400
Nov 17, 2025	$0.8400
Aug 18, 2025	$0.7800
May 19, 2025	$0.7800
Feb 14, 2025	$0.7800
Nov 8, 2024	$0.7800
Aug 12, 2024	$0.7800
May 10, 2024	$0.7800
Feb 15, 2024	$0.7800
Nov 13, 2023	$0.5800
Sep 27, 2023	$0.6000
Aug 15, 2023	$0.5100
Jun 26, 2023	$0.6000
May 15, 2023	$0.5100
Mar 28, 2023	$0.6000
Feb 13, 2023	$0.5100
Dec 23, 2022	$0.7000
Nov 14, 2022	$0.5100
Sep 28, 2022	$1.4000
Aug 15, 2022	$0.4600
Jun 27, 2022	$0.7000
May 16, 2022	$0.4600
Mar 30, 2022	$0.3000